MSD Partners’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,316
| Closed | -$37.7K | – | 17 |
|
|
2024
Q3 | $37.7K | Buy |
27,316
+3,380
| +14% | +$4.66K | 0.02% | 17 |
|
|
2024
Q2 | $141K | Buy |
+23,936
| New | +$141K | 0.01% | 16 |
|
|
2022
Q3 | – | Sell |
-466
| Closed | -$25K | – | 88 |
|
|
2022
Q2 | $25K | Hold |
466
| – | – | ﹤0.01% | 84 |
|
|
2022
Q1 | $33K | Sell |
466
-931
| -67% | -$65.9K | ﹤0.01% | 88 |
|
|
2021
Q4 | $96K | Buy |
1,397
+931
| +200% | +$64K | ﹤0.01% | 109 |
|
|
2021
Q3 | $53K | Hold |
466
| – | – | ﹤0.01% | 102 |
|
|
2021
Q2 | $70K | Sell |
466
-3,377
| -88% | -$507K | ﹤0.01% | 104 |
|
|
2021
Q1 | $655K | Buy |
+3,843
| New | +$655K | 0.02% | 58 |
|
|
2018
Q3 | – | Sell |
-471
| Closed | -$984K | – | 39 |
|
|
2018
Q2 | $984K | Hold |
471
| – | – | 0.04% | 24 |
|
|
2018
Q1 | $1.31M | Hold |
471
| – | – | 0.07% | 19 |
|
|
2017
Q4 | $2.09M | Hold |
471
| – | – | 0.11% | 15 |
|
|
2017
Q3 | $3.84M | Hold |
471
| – | – | 0.11% | 25 |
|
|
2017
Q2 | $2.33M | Hold |
471
| – | – | 0.14% | 30 |
|
|
2017
Q1 | $2.6M | Hold |
471
| – | – | 0.13% | 27 |
|
|
2016
Q4 | $3.14M | Buy |
471
+115
| +32% | +$767K | 0.16% | 25 |
|
|
2016
Q3 | $5.36M | Hold |
356
| – | – | 0.43% | 24 |
|
|
2016
Q2 | $5.61M | Sell |
356
-125
| -26% | -$1.97M | 0.37% | 43 |
|
|
2016
Q1 | $9.93M | Hold |
481
| – | – | 0.52% | 35 |
|
|
2015
Q4 | $9.64M | Hold |
481
| – | – | 0.41% | 36 |
|
|
2015
Q3 | $9.55M | Buy |
481
+71
| +17% | +$1.41M | 0.31% | 43 |
|
|
2015
Q2 | $10.2M | Hold |
410
| – | – | 0.21% | 50 |
|
|
2015
Q1 | $7.85M | Hold |
410
| – | – | 0.19% | 56 |
|
|
2014
Q4 | $5.23M | Buy |
410
+104
| +34% | +$1.33M | 0.12% | 46 |
|
|
2014
Q3 | $4.76M | Hold |
306
| – | – | 0.14% | 47 |
|
|
2014
Q2 | $4.6M | Hold |
306
| – | – | 0.12% | 49 |
|
|
2014
Q1 | $6.88M | Hold |
306
| – | – | 0.26% | 46 |
|
|
2013
Q4 | $4.09M | Buy |
306
+66
| +28% | +$883K | 0.17% | 54 |
|
|
2013
Q3 | $3.53M | Hold |
240
| – | – | 0.13% | 50 |
|
|
2013
Q2 | $3.61M | Buy |
+240
| New | +$3.61M | 0.2% | 40 |
|